Javascript must be enabled to continue!
Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia
View through CrossRef
Currently, national governments of onchocerciasis endemic African countries are working towards the elimination of the disease using mass drug administration (MDA) with ivermectin as a primary strategy. Attainment of this goal requires implementation of prolonged high MDA coverage in all endemic areas, and vigilant monitoring and evaluation of the program. This study was thus conducted with the purpose of i) providing estimate of ivermectin coverage, ii) validating the MDA coverage reported through community drug distributors (CDDs), iii) determining the factors associated with MDA coverage, and iv) estimating the difference between MDA program reach and survey coverage rates following MDA campaign carried out in May 2017 in Asosa and Yeki districts in Ethiopia. A community-based cross-sectional study was conducted among 2,824 study participants in Asosa and Yeki districts. A total of 50 kebeles (smallest administrative units) were randomly selected from the two districts. A systematic sampling was employed to select study households from the 50 kebeles. Then, a household member was randomly selected for the interview. Univariate and multivariate logistic regression analysis were used to determine the odds ratio and to observe the associations between the MDA survey coverage and the variables used. Eighty-seven percent (2458/2824) of the respondents from both districts responded that they were offered ivermectin during the May 2017 MDA campaign. At the district level, 1182 individuals from Yeki and 1276 from Asosa, received the drug, that indicate 88.5% and 85.8% MDA program reach in Yeki and Assosa districts, respectively. Whereas, a total of 366 individuals were not offered ivermectin in both study districts. Of these, 47(12.8%), 143(39.1%), and 176(48.1%) did not receive the drug because of program implementation-related reasons, ineligibility criteria, and personal issues, respectively. Of the 1488 and 1336 respondents in Asosa and Yeki, 1272 and 1182 participants took the drug, resulting in survey coverage rate of 85.5% (95% CI: 83.6–87.2%) and 88.5% (95% CI: 86.7–90.1%), respectively. Multivariable logistic regression analysis revealed significantly low survey coverage rate in females (AOR = 0.5, 95%CI: 0.3–0.6; p<0.001) and in those whose age ranges between 15–24 years (AOR = 0.5, 95%CI: 0.3–0.8; p = 0.007) and 25–34 years (AOR = 0.5, 95%CI: 0.3–0.9; p = 0.021) in Asosa. The researchers believe that the current study generated operational evidence on MDA program reach and coverage rates in two study districts in Ethiopia. The survey coverages were lower than the recommended 90% minimum threshold for success. Only Yeki district reached the 90% threshold survey coverage. Both districts had reported higher coverages than the survey estimates (even outside the 95% CI), thus, were not validated. The majority (60.9%) of the reasons for not receiving the drug were related to program implementation and recipients`personal issues. Efforts must therefore be directed to enhance MDA coverage in future rounds via proper MDA planning and implementation, such as allocating adequate time to the MDA activities, health education, and mobilizing of all segments of the population, including adolescents and the youth. The researchers also recommend such studies to be extended to other MDA programs for other neglected tropical diseases (NTDs).
Public Library of Science (PLoS)
Title: Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia
Description:
Currently, national governments of onchocerciasis endemic African countries are working towards the elimination of the disease using mass drug administration (MDA) with ivermectin as a primary strategy.
Attainment of this goal requires implementation of prolonged high MDA coverage in all endemic areas, and vigilant monitoring and evaluation of the program.
This study was thus conducted with the purpose of i) providing estimate of ivermectin coverage, ii) validating the MDA coverage reported through community drug distributors (CDDs), iii) determining the factors associated with MDA coverage, and iv) estimating the difference between MDA program reach and survey coverage rates following MDA campaign carried out in May 2017 in Asosa and Yeki districts in Ethiopia.
A community-based cross-sectional study was conducted among 2,824 study participants in Asosa and Yeki districts.
A total of 50 kebeles (smallest administrative units) were randomly selected from the two districts.
A systematic sampling was employed to select study households from the 50 kebeles.
Then, a household member was randomly selected for the interview.
Univariate and multivariate logistic regression analysis were used to determine the odds ratio and to observe the associations between the MDA survey coverage and the variables used.
Eighty-seven percent (2458/2824) of the respondents from both districts responded that they were offered ivermectin during the May 2017 MDA campaign.
At the district level, 1182 individuals from Yeki and 1276 from Asosa, received the drug, that indicate 88.
5% and 85.
8% MDA program reach in Yeki and Assosa districts, respectively.
Whereas, a total of 366 individuals were not offered ivermectin in both study districts.
Of these, 47(12.
8%), 143(39.
1%), and 176(48.
1%) did not receive the drug because of program implementation-related reasons, ineligibility criteria, and personal issues, respectively.
Of the 1488 and 1336 respondents in Asosa and Yeki, 1272 and 1182 participants took the drug, resulting in survey coverage rate of 85.
5% (95% CI: 83.
6–87.
2%) and 88.
5% (95% CI: 86.
7–90.
1%), respectively.
Multivariable logistic regression analysis revealed significantly low survey coverage rate in females (AOR = 0.
5, 95%CI: 0.
3–0.
6; p<0.
001) and in those whose age ranges between 15–24 years (AOR = 0.
5, 95%CI: 0.
3–0.
8; p = 0.
007) and 25–34 years (AOR = 0.
5, 95%CI: 0.
3–0.
9; p = 0.
021) in Asosa.
The researchers believe that the current study generated operational evidence on MDA program reach and coverage rates in two study districts in Ethiopia.
The survey coverages were lower than the recommended 90% minimum threshold for success.
Only Yeki district reached the 90% threshold survey coverage.
Both districts had reported higher coverages than the survey estimates (even outside the 95% CI), thus, were not validated.
The majority (60.
9%) of the reasons for not receiving the drug were related to program implementation and recipients`personal issues.
Efforts must therefore be directed to enhance MDA coverage in future rounds via proper MDA planning and implementation, such as allocating adequate time to the MDA activities, health education, and mobilizing of all segments of the population, including adolescents and the youth.
The researchers also recommend such studies to be extended to other MDA programs for other neglected tropical diseases (NTDs).
Related Results
Impact of ivermectin components on Anopheles dirus and Anopheles minimus mosquito survival
Impact of ivermectin components on Anopheles dirus and Anopheles minimus mosquito survival
Abstract
Background
Ivermectin mass drug administration to humans or livestock is a potential vector control tool for malaria elimination. Racemic i...
Onchocerciasis associated epilepsy in South Sudan, an epidemiological, social and entomological study
Onchocerciasis associated epilepsy in South Sudan, an epidemiological, social and entomological study
Onchocerciasis, commonly known as river blindness, is a neglected tropical disease caused by nematode parasite Onchocerca volvulus. It is transmitted to humans through repeated bit...
Onchocerciasis and Non-Communicable Diseases in the Bafut Health District, Cameroon: Knowledge, Attitudes, and Practices Towards Community-Directed Treatment with Ivermectin
Onchocerciasis and Non-Communicable Diseases in the Bafut Health District, Cameroon: Knowledge, Attitudes, and Practices Towards Community-Directed Treatment with Ivermectin
Abstract
Background
Onchocerciasis remains a public health problem in Cameroon despite years of community-directed treatment wi...
Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon
Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon
Abstract
Background
Individuals with high microfilarial loads of Loa loa are at increased risk of neurologic serious adverse (SAE) e...
Current therapeutic applications and pharmacokinetic modulations of ivermectin
Current therapeutic applications and pharmacokinetic modulations of ivermectin
Ivermectin is considered to be a wonder drug due to its broad-spectrum antiparasitic activity against both ectoparasites and endoparasites (under class of endectocide) and has mult...
River Epilepsy—A Preventable Form of Epilepsy
River Epilepsy—A Preventable Form of Epilepsy
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan: A 3-Year Longitudinal, Prospective, Population-Based Study.
...
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
Abstract
Purpose
In areas of Africa where ivermectin is widely used as prophylaxis against neglected tropical diseases, COVID-19 morbidity and mortality are markedly lower...
Prevalence of Onchocerciasis and Associated Factors among Adults Aged ≥ 15 Years in Semen Bench District, Bench Maji Zone, Southwest Ethiopia: Community Based Cross-Sectional Study
Prevalence of Onchocerciasis and Associated Factors among Adults Aged ≥ 15 Years in Semen Bench District, Bench Maji Zone, Southwest Ethiopia: Community Based Cross-Sectional Study
Background. Though onchocerciasis control and elimination through community directed treatment with ivermectin were conducted for the last fifteen years, prevalence of onchocercias...

